PTIX
Price:
$1.7001
Market Cap:
$3.28M
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
Industry
Biotechnology
IPO Date
2021-04-27
Stock Exchange
NASDAQ
Ticker
PTIX
According to Protagenic Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 336.39%. This represents a change of -16.72% compared to the average of 403.91% of the last 4 quarters.
The mean historical ROE of Protagenic Therapeutics, Inc. over the last ten years is 75.07%. The current 336.39% ROE has changed 348.10% with respect to the historical average. Over the past ten years (40 quarters), PTIX's ROE was at its highest in in the March 2025 quarter at 1.63%. The ROE was at its lowest in in the June 2024 quarter at -202.77%.
Average
75.07%
Median
-48.45%
Minimum
-545.33%
Maximum
1.21%
Discovering the peaks and valleys of Protagenic Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 300.06%
Maximum Annual ROE = 1.21%
Minimum Annual Increase = -754.43%
Minimum Annual ROE = -545.33%
| Year | ROE | Change |
|---|---|---|
| 2024 | -545.33% | 300.06% |
| 2023 | -136.31% | 165.17% |
| 2022 | -51.41% | 12.99% |
| 2021 | -45.49% | -120.52% |
| 2020 | 221.68% | -19.69% |
| 2019 | 276.02% | -77.24% |
| 2018 | 1.21% | -754.43% |
| 2017 | -185.35% | 101.72% |
| 2016 | -91.88% | -195.94% |
| 2015 | 95.77% | -98.14% |
The current ROE of Protagenic Therapeutics, Inc. (PTIX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-244.35%
5-year avg
-111.37%
10-year avg
75.07%
Protagenic Therapeutics, Inc.’s ROE is greater than Salarius Pharmaceuticals, Inc. (-401.03%), greater than Lipella Pharmaceuticals Inc. (-685.24%), greater than Artelo Biosciences, Inc. (-496.36%), greater than Indaptus Therapeutics, Inc. (-612.63%), less than Silexion Therapeutics Ltd. (1.22%), greater than Revelation Biosciences, Inc. (-194.47%), less than Carisma Therapeutics, Inc. (162.29%), greater than SciSparc Ltd. (-83.38%), greater than GT Biopharma, Inc. (-715.46%), less than Psyence Biomedical Ltd. (2.41%),
| Company | ROE | Market cap |
|---|---|---|
| -401.03% | $5.22M | |
| -685.24% | $1.43M | |
| -496.36% | $4.04M | |
| -612.63% | $3.78M | |
| 1.22% | $1.81M | |
| -194.47% | $6.02M | |
| 162.29% | $2.05M | |
| -83.38% | $947.25K | |
| -715.46% | $6.73M | |
| 2.41% | $1.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Protagenic Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Protagenic Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Protagenic Therapeutics, Inc.'s ROE?
How is the ROE calculated for Protagenic Therapeutics, Inc. (PTIX)?
What is the highest ROE for Protagenic Therapeutics, Inc. (PTIX)?
What is the 3-year average ROE for Protagenic Therapeutics, Inc. (PTIX)?
What is the 5-year average ROE for Protagenic Therapeutics, Inc. (PTIX)?
How does the current ROE for Protagenic Therapeutics, Inc. (PTIX) compare to its historical average?